Guidance particularly addresses the value of ultrasound in patient-provider shared decision-making in management of care.

And when she did, she was diagnosed with psoriatic arthritis ... disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea. Severe skin reactions that ...

Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.

However, GRAPPA asserts that there is grade A evidence for use of infliximab or etanercept in severe enthesitis ... the target of all treatment strategies in psoriatic arthritis.

The Simponi biosimilar, AVT05, has shown positive top-line results in patients with moderate to severe rheumatoid arthritis.

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...

The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...

Kristen Whitney, DO, FAAD, dermatologist at Allegheny Health Network, explored the intricate management of alopecia areata, ...

A young woman who isn’t expected to live past 50 is hitting out at NDIS funding claiming decisions being made are a “mind ...

In October 2023, the full dataset from the MIRA trial at 24 weeks showed that maintenance treatment with sonelokimab led to ... and obesity. About Psoriatic Arthritis Psoriatic arthritis (PsA) is a ...

Former Strictly star and Emmerdale actor Adam Thomas has shared an update on his health battle, saying he can 'barely walk' ...

Medically reviewed by Doru Paul, MD To confirm a psoriasis diagnosis, your healthcare provider will check your skin and scalp ...